News - 2021
December 31, 2021 Event
Oblique’s Therapeutics AB (publ.) presentation at the virtual J.P. Morgan Healthcare Conference
scheduled for Monday, January 10, 2022
December 6, 2021 News
Award – Oblique Therapeutics AB (publ.) a Top Immunotherapy solution providers
in Europe 2021
November 25, 2021 News
Oblique Therapeutic’s AB (publ.) interim report for
January – September 2021 (Q3 2021) is available.
November 18, 2021 Event
Oblique Therapeutics AB (publ.) will be at the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit
February 22- 24, 2022 Boston MA
November 16, 2021 News
Oblique Therapeutics AB (publ.) welcomes Cecilia Larsson
as IRM - Investor Relations Manager position at the Gothenburg Office
November 16, 2021 News
Oblique Therapeutics AB (publ.) welcomes Mats Lindskog
as CBO - Chief Business Officer working out from Stockholm Office
October 14, 2021 Event
Oblique Therapeutics AB (publ.) presents its anti-Thioredoxin mAb program
at the annual meeting of Society for Immunotherapy of Cancer, Nov 10 – 14, Washington DC, USA.
October 6, 2021 News
New Press Article in Svenska Dagbladet
in the INNOVATIVA FÖRETAG edition - October 2021
October 5, 2021 News
Nobel Prize 2021 in Physiology or Medicine
for discoveries of receptors for temperature and touch.
October 4, 2021 News
Oblique Therapeutics AB (publ). announces that it has reached a key milestone
in its aKRAS antibody program and achieved validation of its Abiprot® platform.